SyntheticMR announced that they have reached an agreement with one of their partners. This signed agreement means a commitment that the product package SyMRI NEURO will be sold globally in a significant volume. The agreement has great strategic value for the company and the sales value amounts to at least SEK 15 million.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
27.7 SEK | +1.09% | -.--% | +4.14% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.14% | 108M | |
+9.08% | 33.88B | |
+21.99% | 8.35B | |
+31.37% | 4.24B | |
-30.21% | 2.67B | |
-19.04% | 1.45B | |
-24.21% | 1.33B | |
-33.21% | 1.16B | |
+12.79% | 1B | |
-34.50% | 892M |
- Stock Market
- Equities
- SYNT Stock
- News SyntheticMR AB
- SyntheticMR Signs Sales Agreement Regarding SyMRI NEURO